Index Resource Center

Athene offers additional index options through our registered index-linked product series, Amplify 2.0, and the Athene BCA suite of fixed indexed annuities, powered by Annexus. For more information, please visit: Amplify 2.0 or Athene BCA.

^* The full name of the S&P 500 FC Index is S&P 500 FC TCA 0.50% Decrement Index (USD) ER.

AI Powered Global Opportunities Index • The AI Powered Global Opportunities Index (the “AiGO Index”) is the exclusive property of EquBot Inc (“EquBot”) and administered, calculated, and published by MerQube, Inc. (“MerQube”).

AI Powered US Equity Index • The AI Powered US Equity Index (the “AiPEX Index”) is the exclusive property of EquBot and is administered, calculated, and published by Solactive AG (“Solactive”).

AI Powered Multi-Asset Index • The AI Powered Multi-Asset Index (the “AiMAX Index”) is the exclusive property of EquBot and is administered, calculated, and published by Solactive. We also refer to each of the AiGO Index, the AiPEX Index and the AiMAX Index herein as an “Index” and, together, the “Indices.”

Equbot, AiGO, AiPEX, AiMAX, “AI Powered Global Opportunities Index”, “AI Powered US Equity Index” and “AI Powered Multi-Asset Index” (collectively, the “Marks”) are trademarks or service marks of EquBot and have been licensed by HSBC and sub-licensed by Athene Annuity and Life Company (the “Company”) for use in a fixed indexed annuity offered by the Company. The fixed indexed annuity is not, in whole or in part, sponsored, structured, priced, endorsed, offered, sold, issued or promoted by EquBot, HSBC, MerQube, Solactive or any of their affiliates. EquBot and HSBC’s only relationship to the Company is the licensing of the Indices and Marks for certain purposes. MerQube and Solactive’s only relationship to the Company is with respect to administering, calculating and publishing the indices. EquBot, HSBC, MerQube and Solactive shall not have any liability with respect to a fixed indexed annuity in which an interest crediting option is based on an Index and are not liable for any loss relating to the fixed indexed annuity, whether arising directly or indirectly from the use of an Index, its methodology, any Mark or otherwise. None of EquBot, HSBC, MerQube or Solactive have any obligation to take into consideration any of the needs of the Company or any of the owners, annuitants or beneficiaries of the fixed indexed annuity in designing, calculating, administering or licensing the Indices.

NONE OF EQUBOT, HSBC, MERQUBE, SOLACTIVE OR THEIR SUPPLIERS GUARANTEES THE ACCURACY, ADEQUACY, TIMELINESS, COMPLETENESS OR AVAILABILITY OF THE AIGO INDEX OR ANY COMPONENT THEREOF OR DATA INCLUDED THEREIN, OR THAT NO ERROR, OMISSION, DELAY OR INTERRUPTION WILL EXIST THEREIN. NONE OF EQUBOT, HSBC, MERQUBE, SOLACTIVE OR THEIR SUPPLIERS MAKES ANY REPRESENTATION OR WARRANTY, AND EACH OF HSBC, EQUBOT, MERQUBE, SOLACTIVE AND THEIR SUPPLIERS EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, THOSE REGARDING (I) MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, AND (II) THE ADVISABILITY OF ANY PERSON INVESTING IN THE FIXED INDEXED ANNUITY.

No purchaser, seller or holder of the fixed indexed annuity, or any other person or entity, should use or refer to any Mark or other EquBot trade name to sponsor, endorse, market or promote the fixed indexed annuity without a license from EquBot and HSBC. Under no circumstances may any person or entity claim any affiliation or
association with EquBot, HSBC, MerQube or Solactive without the prior written permission of EquBot, HSBC, MerQube or Solactive.

In calculating the performance of each of the Indices, EquBot deducts a servicing cost of 0.85% per annum for the AiGO Index, a servicing cost of 0.50% per annum for the AiPEX Index, and a servicing cost of 0.75% per annum for the AiMAX Index, each calculated on a daily basis. Such costs may vary over time with market conditions. These costs reduce the potential positive change in the Indices and thus the amount of interest that will be credited to the fixed indexed annuity option based on each of the Indices.

The volatility control applied by Equbot may reduce the potential positive or negative change in each of the Indices and thus the amount of interest that will be credited to the fixed indexed annuity option that is based on either of the Indices.

Nothing provided herein should be construed as HSBC, Equbot, MerQube, Solactive or any of their suppliers providing tax, legal, or investment advice nor are HSBC, EquBot, MerQube, Solactive or any of their suppliers recommending engaging in any investment strategy or transaction.

BNP Paribas Multi Asset Diversified 5 Index • The BNP Paribas Multi Asset Diversified 5 Index (the “BNPP MAD 5 Index”) is the exclusive property of BNP Paribas or one of its affiliates (BNP Paribas and its affiliates are hereinafter called “BNPP”) and is determined, composed and calculated by BNPP. “BNP”, “BNPP”, “BNP Paribas”, “BNPP MAD 5 Index” and “BNP Paribas Multi Asset Diversified 5 Index” (collectively, the “BNPP Marks”) are trademarks or service marks of BNPP and have been licensed by Athene Annuity and Life Company (the “Company”) for use in a fixed indexed annuity offered by the Company. The fixed indexed annuity is not, in whole or in part, sponsored, structured, priced, endorsed, offered, sold, issued or promoted by BNPP or any of its affiliates, or any third party licensor of information to BNPP. BNPP’s only relationship to the Company is the licensing of the BNPP MAD 5 Index and BNPP Marks for certain purposes. BNPP shall not have any liability with respect to a fixed indexed annuity in which an interest crediting option is based on the BNPP MAD 5 Index, and is not liable for any loss relating to the fixed indexed annuity, whether arising directly or indirectly from the use of the BNPP MAD 5 Index, its methodology, any BNPP Mark or otherwise.

In calculating the level of the BNPP MAD 5 Index, BNPP deducts a servicing cost of 0.50% per annum, calculated on a daily basis. In addition, the BNPP MAD 5 Index methodology embeds certain costs which cover among other things, rebalancing and replication costs. Such costs may vary over time with market conditions. These costs reduce the potential positive change in the BNPP MAD 5 Index and thus the amount of interest that will be credited to the fixed indexed annuity that includes the BNPP MAD 5 Index.

Nasdaq FC Index • BofA Securities, Inc. and its affiliates (“BofAS”) indices and related information, the name “BofAS”, and related trademarks, are intellectual property licensed from BofAS, and may not be copied, used, or distributed without BofAS’s prior written approval. The products of licensee Athene Annuity and Life Company have not been passed on as to their legality or suitability, and are not regulated, issued, endorsed, sold, guaranteed, or promoted by BofAS. BOFAS MAKES NO WARRANTIES AND BEARS NO LIABILITY WITH RESPECT TO ANY INDEX, ANY RELATED INFORMATION, ITS TRADEMARKS, OR THE PRODUCT (INCLUDING WITHOUT LIMITATION, ITS QUALITY, ACCURACY, SUITABILITY AND/OR COMPLETENESS).

Nasdaq^® is a registered trademark of NASDAQ, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by BofA Securities, Inc. The Product has not been passed on by the Corporations as to its legality or suitability. The Product is not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT.

S&P Indices • The S&P 500^® and S&P 500^® FC TCA 0.50% Decrement Index (USD) ER (the “Indices”) are products of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”) and have been licensed for use by Athene Annuity and Life Company (“Athene”). S&P^®, S&P 500^®, US 500^®, The 500^®, iBoxx^®, iTraxx^® and CDX^® are trademarks of S&P Global, Inc. or its affiliates (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”). Fast Convergence and FC are trademarks of BofA Securities, Inc. and/or its affiliates (“BofAS”). BofAS has licensed the Fast Convergence (FC) patented methodology (“Methodology”) and related trademarks to SPDJI for use in the S&P 500^® FC TCA 0.50% Decrement Index (USD) ER. Athene’s products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, BofAS, or their respective affiliates and none of such partiesmake any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the Indices.

Shiller Barclays CAPE^® Allocator 6 Index • The Shiller Barclays CAPE^® Allocator 6 Index has been developed in part by RSBB-I, LLC, the research principal of which is Robert J. Shiller. RSBB-I, LLC is not an investment advisor, and does not guarantee the accuracy or completeness of the Shiller Barclays CAPE^® Allocator 6 Index, or any data or methodology either included therein or upon which it is based. Neither RSBB-I, LLC nor Robert J. Shiller or any of their respective partners, employees, subcontractors, agents, suppliers and vendors (collectively, the “Protected Parties”) shall have any liability, whether caused by the negligence of a Protected Party or otherwise, for any errors, omissions, or interruptions therein, and make no warranties, express or implied, as to performance or results experienced by any party from the use of any information included therein or upon which it is based, and expressly disclaim all warranties of merchantability or fitness for a particular purpose with respect thereto, and shall not be liable for any claims or losses of any nature in connection with the use of such information, including but not limited to, lost profits or punitive or consequential damages, even if RSBB-I, LLC, Robert J. Shiller or any Protected Party is advised of the possibility of same.
Neither Barclays Bank PLC (“BB PLC”) nor any of its affiliates (collectively “Barclays”) is the issuer or producer of Athene fixed index annuities (the “Products”) and Barclays has no responsibilities, obligations or duties to purchasers of the Products. The Shiller Barclays CAPE^® Allocator 6 Index (the “Index”), together with any Barclays indices that are components of the Index, is a trademark owned by Barclays and, together with any component indices and index data, is licensed for use by Athene Annuity and Life Company (“Athene”) as the issuer or producer of the Products (the “Issuer”).
Barclays’ only relationship with the Issuer in respect of the Index is the licensing of the Index, which is administered, compiled and published by BB PLC in its role as the Index sponsor (the “Index Sponsor”) without regard to the Issuer or the Products or purchasers of the Products. Additionally, Athene as issuer or producer of the Products may for itself execute transaction(s) with Barclays in or relating to the Index in connection with the Products. Consumers acquire the Products from Athene and neither acquire any interest in the Index nor enter into any relationship of any kind whatsoever with Barclays upon purchasing the Products. The Products are not sponsored, endorsed, sold or promoted by Barclays and Barclays makes no representation regarding the advisability of the Products or use of the Index or any data included therein. Barclays shall not be liable in any way to the Issuer, purchasers of the Products or to other third parties in respect of the use or accuracy of the Index or any data included therein.

UBS Innovative Balanced Index • UBS AG and its affiliates (“UBS”) do not sponsor, endorse, sell, or promote any Athene annuity (the “Product”). A decision to purchase the Product should not be made in reliance on any of the statements set forth in this material. Prospective purchasers are advised to purchase the Product only after carefully considering the risks associated with the Product, as detailed in a disclosure document or prospectus that is prepared by or on behalf of Athene Annuity and Life Company (“Licensee”), the issuer of the Product. UBS has licensed certain UBS marks and other data to Licensee for use in connection with the Product and the branding of the Product, but UBS is not involved in the calculation of the Product, the construction of the Product’s methodology or the creation of the Product. Nor is UBS involved in the sale or offering of the Product, and UBS does not make any representations or warranties with respect to the Product.